loadpatents
name:-0.036539077758789
name:-0.040524959564209
name:-0.008141040802002
Suto; Mark J. Patent Filings

Suto; Mark J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Suto; Mark J..The latest application filed is for "2,4,7-substituted-7-deaza-2'-deoxy-2'-fluoroarabinosyl nucleoside and nucleotide pro-drugs and uses thereof".

Company Profile
6.35.30
  • Suto; Mark J. - Homewood AL
  • Suto; Mark J. - Birmingham AL
  • Suto; Mark J. - Chapel Hill NC
  • Suto; Mark J. - San Diego CA
  • Suto; Mark J. - La Jolla CA
  • Suto; Mark J. - San Deigo CA
  • Suto; Mark J. - Ann Arbor MI
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Polymorophs of 5-aza-4'-thio-2'-deoxycytidine
Grant 11,447,472 - Suto , et al. September 20, 2
2022-09-20
2,4,7-substituted-7-deaza-2'-deoxy-2'-fluoroarabinosyl Nucleoside And Nucleotide Pro-drugs And Uses Thereof
App 20220251134 - Moukha-Chafiq; Omar ;   et al.
2022-08-11
Thiarabine- And Thiarabine Prodrug-based Treatments
App 20220241310 - Moukha-Chafiq; Omar ;   et al.
2022-08-04
Compounds for the Treatment Of Acute and Chronic Kidney Disease
App 20220153702 - Suto; Mark J. ;   et al.
2022-05-19
Compounds for the Treatment Of Acute and Chronic Kidney Disease
App 20220153695 - Suto; Mark J. ;   et al.
2022-05-19
Polymorophs Of 5-aza-4'-thio-2'-deoxycytidine
App 20220024903 - Suto; Mark J. ;   et al.
2022-01-27
Substituted Quinazoline Sulfonamides As Thioredoxin Interacting Protein (txnip) Inhibitors
App 20210369713 - Augelli-Szafran; Corinne E. ;   et al.
2021-12-02
4'-thio-nucleotide And -nucleoside Prodrugs For The Treatment Of Cancer
App 20210363170 - MOUKHACHAFIQ; Omar ;   et al.
2021-11-25
Composition For Treating Blood Cancer Using 4'-thio-5-aza-2'-deoxycytidine And Uses Thereof
App 20210330689 - Suto; Mark J. ;   et al.
2021-10-28
Piperazine-2,5-diones As Tgf-beta Inhibitors
App 20210323933 - Suto; Mark J. ;   et al.
2021-10-21
Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors
Grant 11,103,508 - Augelli-Szafran , et al. August 31, 2
2021-08-31
2,5-aryl-thiazole Analogs For The Treatment Of Neurodegenerative Diseases
App 20210246110 - Suto; Mark J. ;   et al.
2021-08-12
Benzoannulene derivatives as antiviral agents
Grant 11,066,357 - Pathak , et al. July 20, 2
2021-07-20
Dipeptide analogs as TGF-beta inhibitors
Grant 11,046,729 - Suto , et al. June 29, 2
2021-06-29
2-aminoaryl-5-aryloxazole Analogs For The Treatment Of Neurodegenerative Diseases
App 20210188791 - Suto; Mark J. ;   et al.
2021-06-24
Oxadiazoles and thiadiazoles as TGF-.beta. inhibitors
Grant 11,033,535 - Suto , et al. June 15, 2
2021-06-15
Benzoannulene Derivatives As Antiviral Agents
App 20210078937 - Pathak; Ashish Kumar ;   et al.
2021-03-18
Oxadiazoles And Thiadiazoles As Tgf-beta Inhibitors
App 20200222371 - Suto; Mark J. ;   et al.
2020-07-16
Oxadiazoles and thiadiazoles as TGF-.beta. inhibitors
Grant 10,653,682 - Suto , et al.
2020-05-19
Substituted Quinazoline Sulfonamides As Thioredoxin Interacting Protein (txnip) Inhibitors
App 20200038402 - Augelli-Szafran; Corinne E. ;   et al.
2020-02-06
Dipeptide Analogs As Tgf-beta Inhibitors
App 20190127420 - Suto; Mark J. ;   et al.
2019-05-02
Oxadiazoles And Thiadiazoles As Tgf-beta Inhibitors
App 20190125730 - Suto; Mark J. ;   et al.
2019-05-02
Benzimidazole Compounds, Use As Inhibitors of WNT Signaling Pathway in Cancers, and Methods for Preparation Thereof
App 20170210741 - AUGELLI-SZAFRAN; Corinne E. ;   et al.
2017-07-27
Treatment Of Hepatitis B Viral
App 20160303122 - Suto; Mark J.
2016-10-20
Antiviral agents
Grant 9,375,419 - Suto June 28, 2
2016-06-28
Antiviral Agents
App 20160166557 - Suto; Mark J.
2016-06-16
Compounds, compositions and methods for the treatment of diseases through inhibiting TGF-.beta. activity
Grant 9,353,149 - Suto , et al. May 31, 2
2016-05-31
Heterocycles as potassium channel modulators
Grant 9,018,208 - Christos , et al. April 28, 2
2015-04-28
Chemical compounds
Grant 8,927,587 - Bagal , et al. January 6, 2
2015-01-06
Sodium Channel Inhibitors
App 20140357685 - Beaudoin; Serge ;   et al.
2014-12-04
Compounds, Compositions and Methods for the Treatment of Diseases Through Inhibiting TGF- Activity
App 20140336115 - Suto; Mark J. ;   et al.
2014-11-13
Sodium channel inhibitors
Grant 8,853,250 - Beaudoin , et al. October 7, 2
2014-10-07
Chemical Compounds
App 20130274243 - Bagal; Sharanjeet Kaur ;   et al.
2013-10-17
Heterocycles As Potassium Channel Modulators
App 20130143889 - Christos; Thomas Eugene ;   et al.
2013-06-06
Heterocycles as potassium channel modulators
Grant 8,431,608 - Christos , et al. April 30, 2
2013-04-30
Inhibitors of ion channels
Grant 8,063,080 - Fulp , et al. November 22, 2
2011-11-22
Heterocycles as potassium channel modulators
Grant 8,058,274 - Christos , et al. November 15, 2
2011-11-15
Calcium channel antagonists
Grant 8,034,954 - Pacofsky , et al. October 11, 2
2011-10-11
Sodium Channel Inhibitors
App 20100267782 - Beaudoin; Serge ;   et al.
2010-10-21
Heterocycles As Potassium Channel Modulators
App 20100240663 - Christos; Thomas Eugene ;   et al.
2010-09-23
Inhibitors Of Ion Channels
App 20100041707 - Fulp; Alan ;   et al.
2010-02-18
Inhibitors of ion channels
Grant 7,615,569 - Fulp , et al. November 10, 2
2009-11-10
Heterocycles As Potassium Channel Modulators
App 20090062290 - Christos; Thomas Eugene ;   et al.
2009-03-05
Calcium Channel Antagonists
App 20070197523 - Pacofsky; Gregory J. ;   et al.
2007-08-23
Calcium Channel Antagonists
App 20070173504 - Pacofsky; Gregory J. ;   et al.
2007-07-26
Inhibitors Of Ion Channels
App 20070078145 - Fulp; Alan ;   et al.
2007-04-05
Cytokine restraining agents
Grant 6,245,738 - Suto , et al. June 12, 2
2001-06-12
Quinazoline analogs and related compounds and methods for treating inflammatory conditions
Grant 5,939,421 - Palanki , et al. August 17, 1
1999-08-17
Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions
Grant 5,935,966 - Suto , et al. August 10, 1
1999-08-10
Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
Grant 5,811,428 - Suto , et al. September 22, 1
1998-09-22
Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
Grant 5,786,332 - Girten , et al. July 28, 1
1998-07-28
Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
Grant 5,760,001 - Girten , et al. June 2, 1
1998-06-02
Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
Grant 5,726,156 - Girten , et al. March 10, 1
1998-03-10
Cytokine restraining agents
Grant 5,420,109 - Suto , et al. May 30, 1
1995-05-30
Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
Grant 5,177,075 - Suto , et al. January 5, 1
1993-01-05
Quinolinecarboxylic acid antibacterial agents
Grant 5,116,834 - Domagala , et al. May 26, 1
1992-05-26
Purine derivatives
Grant 5,098,906 - Sircar , et al. March 24, 1
1992-03-24
Aziridino derivatives of nitroimidazoles and pharmaceutical compositions of selected derivatives
Grant 5,036,096 - Suto July 30, 1
1991-07-30
2-oxazolidinone derivatives of nitroimidazoles and pharmaceutical compositions useful as sensitizing agents
Grant 5,036,089 - Suto July 30, 1
1991-07-30
Purine derivatives
Grant 4,921,859 - Sircar , et al. May 1, 1
1990-05-01
Purine derivatives
Grant 4,806,642 - Sircar , et al. February 21, 1
1989-02-21
2-nitroimidazole derivatives useful as radiosensitizers for hypoxic tumor cells
Grant 4,797,397 - Suto , et al. January 10, 1
1989-01-10
Substituted benzonitriles
Grant 4,677,219 - Berman , et al. June 30, 1
1987-06-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed